Colgate-Palmolive (CL) Target Raised as Analysts Split on 2026 Staples Outlook

Colgate-Palmolive Company (NYSE:CL) is included among the 14 Best Dividend Aristocrats to Invest in Heading into 2026.

Colgate-Palmolive (CL) Target Raised as Analysts Split on 2026 Staples Outlook

On December 19, BofA raised its price target on Colgate-Palmolive Company (NYSE:CL) to $90 from $88 and kept a Buy rating. Looking ahead to 2026, the firm said the biggest open question for consumer staples is still consumption growth. Valuations remain uneven across the sector, and “there feels little to get them off the sidelines in ’26 until fundamentals signal a greater turning of the tide,” the analyst wrote in a year-ahead note.

Two days earlier, on December 17, Jefferies struck a more constructive tone on the household and personal care space. The firm pointed to easing macro pressures, improving views on key categories, and what it sees as a strong lineup of new products in the year ahead. Jefferies remained more cautious on Colgate-Palmolive Company (NYSE:CL), citing softer expectations for oral care and slowing demand in premium pet products as reasons for its more reserved stance.

In its third-quarter 2025 earnings report, the company described a challenging operating backdrop. Management pointed to pressures from “consumer uncertainty, tariffs, geopolitics, high cost inflation and other factors” that weighed on sales and profit growth across the industry. The company reiterated its focus on its 2030 Strategy. It highlighted a portfolio of healthy brands in growing categories, strong market positions, and a broad global footprint. Nearly 50% of revenue exposure comes from faster-growing emerging markets, supported by what management described as a best-in-class global supply chain.

Colgate-Palmolive Company (NYSE:CL) is a global consumer products company that manufactures and markets everyday household staples, with a core focus on oral care, personal care, and home care products.

While we acknowledge the potential of CL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CL and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 14 Best Pharma Dividend Stocks to Buy in 2026 and 15 Global Dividend Stocks to Diversify Your Portfolio.

Disclosure: None.